| Literature DB >> 12498018 |
Abstract
The depsipeptide FR-901228 is a histone deacetylas inhibitor under development by Fujisawa and the National Cancer Institute as a potential treatment for neoplasm. By May 2002, phase II trials had commenced in the US [452248], [461017].Entities:
Mesh:
Substances:
Year: 2002 PMID: 12498018
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN: 1472-4472